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Abstract  
In this study, the second use of an intravaginal progesterone-releasing device or controlled intravaginal 
drug release device (CIDR) was evaluated. After a first use of 11 days, the CIDR was again used for either 
nine or 12 days with 200 or 300 IU equine chorionic gonadotrophin (eCG) being injected on its removal. 
Sixty-four ewes were randomly distributed to four treatments (n=16/group): CIDR9+eCG200, 
CIDR9+eCG300, CIDR12+eCG200, and CIDR12+eCG300. The eCG was administered intramuscularly on 
withdrawal of the device. Thus, the experiment was a completely randomized design with a 2×2 factorial 
arrangement of treatments. Oestrus presentation did not differ between treatments (P =0.29). However, with 
the dose of 200 IU of eCG, oestrus presentation tended to increase (P =0.08). The onset and duration of 
oestrus, percentage of gestation, and return to oestrus did not differ between treatments (P >0.05). 
Progesterone concentration in serum was greater (P < 0.05) in ewes treated with CIDR12+eCG300. 
Prolificacy was greatest (1.44) with the CIDR12+eCG300 treatment and was different (P = 0.001) from the 
treatments CIDR9+eCG200 (1.21) and CIDR9+eCG300 (1.20), but not from the CIDR12+eCG200 treated 
ewes (1.31). The CIDR12+eCG300 treatement produced the highest percentage of twin births (45.8%) (P 
=0.001). Leaving the device in place for 12 days increased (P =0.001) the incidence of twin births. Use of the 
CIDR for a second time synchronized oestrus in ewes successfully with better fertility being obtained when 
the device was left in place for 12 days, and 300 IU of eCG was injected on its removal. 
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Oestrous synchronization has been used for a long time. However, with the increase in knowledge of 
the dynamics of follicular development (Ginther et al., 1995), experiments have been focused on 
concentrating the oestrus period to a shorter time if artificial insemination is desired. On the other hand, with 
the increasing demand to be environmentally friendly and with the costs to the producers in mind, efforts 
have focused on reusing progesterone-releasing devices without affecting their efficiency, and making their 
use more affordable.  
To improve the profitability of intensive sheep production, it is necessary to increase reproductive 
efficiency by increasing fertility, prolificacy and the frequency of births. Reproductive seasonality in sheep is 
a limiting factor to achieving the goal of three parturitions in two years (Rosa et al., 2003). To overcome this 
limitation various reproductive strategies have been studied. These include treatments with exogenous 
hormones and their synthetic analogues, melatonin implants either separately or in combination (Abecia et 
al., 2011). These treatments induce and synchronize ovulation and oestrus in the reproductive period or 
during the periods of reproductive transition and anoestrus with varying degrees of success (Abecia et al., 
2012; Laven, 2019). 
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Controlled intravaginal release devices with natural progesterone (P4) stimulate the induction and 
synchronization of oestrus for a prolonged time (from 12 to 14 days) in ewes (Wheaton et al., 1993; Escobar 
et al., 2017; Menchaca et al., 2017). This increases the percentage of ewes in oestrus, but with variable 
effects on fertility (Menchaca & Rubianes, 2004). Controlled intravaginal release devices provide a high 
serum P4 concentration immediately after insertion because of their efficient kinetic release, which falls 
dramatically after the removal of the device, but with no cumulative effect (Mohan, 2017). Prolonged 
exposure to P4 in hormonal procedures normally increases the diameter of the ovulatory follicle, but 
decreases the number of ovulatory follicles (Bartlewski et al., 2017). To reduce the negative effect of long 
procedures, reproductive effectiveness has been evaluated with medium (8 to 10 days) and short (5 to 7 
days) protocols using intravaginal devices to synchronize oestrus in ewes (Martinez-Ros et al., 2019b; 
Swelum et al., 2016; Swelum et al., 2018a). 
For progesterone treatment to be effective, an adequate amount of gonadotropin is necessary to 
trigger preovulatory events, so when the CIDR device is removed, eCG is injected to result in similar 
functions to follicle-stimulating hormone (FSH) and luteinizing hormone (LH) (Murphy, 2012; Martinez-Ros et 
al., 2019a).  Equine chorionic gonadotrophin can also be used to accelerate puberty, induce oestrus, 
improve fertility, induce multiple ovulation for embryo transfer procedures, and induce a greater synchrony of 
ovulation in sheep (Ramos & Silva, 2018). The application of eCG after the removal of the CIDR ensures the 
occurrence of fertile ovulations (Martinez-Ros et al., 2019b; Uriol et al., 2019), reduces the interval from 
oestrus to ovulation, and increases the corpus luteum (CL) diameter (Cox et al., 2012). Generally, 
recommended doses of eCG vary from 250 to 500 IU zBarret et al., 2004), depending on weight, age (250–
300 in young ewes, 350 - 500 IU in adult ewes), season (400 - 500 IU in anoestrus, 300 - 500 IU in cyclic 
ewes) and breed (lower doses in prolific breeds) (Abecia et al., 2011).  
Controlled intravaginal drug release devices are effective in inducing and synchronizing oestrous in 
sheep. An addition, they can release limited amounts of P4 for a longer period of time than necessary for 
synchronization and due to their physical characteristics the devices can be disinfected and sterilized 
(Ungerfeld et al., 2013; Chacher et al., 2017). However, they are costly compared with sponges, which limits 
their generalized use in commercial farms, and having to be disposed of after the first use causes 
environmental contamination owing to the residual hormone they contain (Biehl et al., 2019). For this reason, 
research has been conducted to determine the efficiency of induction and synchronization of oestrous with 
reused CIDRs in anoestrus sheep and during the reproductive season (Güngör et al., 2009; Pinna et al., 
2012; Swelum et al., 2018b). Likewise, their use has been evaluated in short experiments (Cox et al., 2012; 
Vilariño et al., 2013; Bazzan et al., 2013) and for multiple times (Da Silva et al., 2014; Swelum et al., 2015; 
Swelum et al., 2018b).  The devices seem to be effective in the second or third use, mainly when combined 
with eCG. However, there is no consensus in the literature that short procedures of oestrous synchronization 
improve the pregnancy rate compared with longer ones. For example, Blaschi et al. (2014) obtained a high 
pregnancy rate with long protocols (83.3%) (14 days) compared with short ones (47.8%) (5 days) and with 
medium duration (60%) (9 days). On the contrary, Viñoles et al. (2001) reported greater pregnancy rate with 
a short protocol (87%) (6 days) compared with a 12-day treatment (67%).  
Therefore, the objective of this study was to evaluate the effects on the main reproductive variables 
and serum progesterone concentration of primal ewes of the reuse of the CIDR device with two periods of 
duration (9 and 12 days) and two doses of eCG (200 and 300 IU). 
 
Material and Methods 
The study was performed in July 2018, during the season of reproductive transition (light/dark hours 
13L/11D), at the experimental farm of the Colegio de Postgraduados, Campus Montecillo, México, at 19° 29’ 
N, 98° 53’ W and and 2250 metres above sea level. The climate is mild, with an average annual rainfall of 
632.5 mm in summer and an annual average temperature of between 12 °C and 18 °C (García, 2004).  The 
handling of the animals was carried out according to the standards of Animal Welfare and Ethics of the 
Colegio de Postgraduados, México, in compliance with the Official Mexican Standard NOM-062-ZOO-1999 
(SAGARPA, 2001). 
In the present study, 64 primal ewes (13 months old) were used. These were a Katahdin × Suffolk 
hybrid, with 54 ± 3.1 kg of initial bodyweight, having been dewormed with Ivomec
®
 (1 mL per 50 kg of 
bodyweight) subcutaneously and supplemented with Vigantol ADE
® 
(1 ml) intramuscularly, with a body 
condition score of 3 in a score of 1 to 5. During the experiment, all ewes were fed daily with a diet based on 
oat hay (Avena sativa), alfalfa hay (Medicago sativa) and 250 g commercial concentrate with 14% crude 
protein (CP). Water and mineral salts were offered ad libitum. 
A device that consisted of silicon elastomers (CIDR
®
, Zoetis, México) impregnated with 0.3 g natural 
P4 was inserted intravaginally in each ewe. The devices had previously been used in an 11-day 
synchronization protocol two months before the present study at the same experimental farm. The devices 




were washed with purified water after first use, dried and placed in airtight bags for refrigerated storage. One 
day before their second use they were exposed to room temperature to avoid moisture in the devices. At the 
time that the device was inserted, the vulva area was cleaned and bactericidal ointment (Furacine
®
, PiSA, 
México) was applied to the applicator to prevent infection. 
The ewes were randomly distributed in four treatments (n = 16/group), namely CIDR9+eCG200, 
CIDR9+eCG300, CIDR12+eCG200 and CIDR12+eCG300, which combine the days of duration of the device 
(9 or 12 days) and the dose of eCG (200 or 300 IU). The eCG hormone (Folligon
® 
Intervet, México) was 
injected intramuscularly when the device was removed. 
Oestrus detection began at 24 hours after the removal of the CIDR with controlled mating with males 
of proven fertility. They were subsequently monitored every six hours for 72 hours to determine the duration 
and end of the oestrous. The ewes received three mounts: the first at the start of oestrus, and two later at 12-
hour intervals. The return to oestrus was detected in two periods (morning and afternoon) from 15 to 18 days 
after mating with fertile males. The ewes that returned to oestrus received three more mounts. Pregnancy 
was diagnosed 30 and 60 days after the mount with a Sonovet 600
®
 ultrasound with a 7.5 MHz linear 
transrectal transducer to observe embryonic structures (Figure 1). To determine the pregnancy rate, the 
number of ewes that were diagnosed as pregnant was divided by the number of ewes that had been 
mounted. The prolificacy index was obtained by dividing the number of lambs born by the number of 
















Figure 1 Experimental protocol for oestrous synchronization in ewes with a reused controlled intravaginal 
release device and equine chorionic gonadotrophin  
       blood sample collection; CIDR: controlled intravaginal release device; eCG: equine chorionic gonadotrophin 
 
 
Blood samples were collected from 10 ewes per treatment to determine the P4 levels. Samples were 
collected in polypropylene tubes (5 mL) by puncturing the jugular vein at 8h00, one day before the insertion 
of the CIDR, on days 2, 4, 7, and 8, two days after the device was removed, and subsequently every 48 
hours. All samples were centrifuged at 1500 g for 20 min at 4 °C to separate the blood serum, which was 
stored in Eppendorf tubes at -20 °C until analysis. To determine the P4 concentration, a radioimmunoassay 
was carried out with the commercial kit PROG-CTRIA® (Cisbio International, France) with an intra and inter 
assay coefficient of variation of 4.1 and 8.7, respectively, and a sensitivity of 0.05 ng mL
-1
.  
The experimental design was completely randomized with a 2 × 2 factorial arrangement, in which the 
main effects were the duration of use for the reused CIDR (9 and 12 days) and the level of eCG (200 and 
300 IU). Data analyses were conducted using SAS, version 9.1 (SAS Institute, Inc., Cary, North Carolina, 
USA).. The variables of oestrous onset, return to oestrus, percentage of pregnancy, prolificacy index and 
type of birth were analysed with an X
2
 test using PROC FREQ. Time to the beginning of oestrus and its 
duration, were analysed with PROC GLM and Tukey’s test was used to assess differences between the 
treatment means. The P4 concentrations were analysed with PROC MIXED and the Tukey test was 
performed to determine the differences between treatment means (P≤0.05).  
 
Results and Discussion  
Oestrus response did not differ between treatments (P =0.285). However, with the dose of 200 IU of 
eCG it tended (P =0.078) to increase (Table 1). The high percentage of ewes that showed oestrus behaviour 
(95.31%) in response to the reused CIDR suggests that in the second use CIDRs still contain enough P4 to 
cause LH blockage and allow the brain to respond to concentrations of circulating oestradiol, so that 
Insertion of CIDR Removal of CIDR 
Administration of eCG 
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oestrous behaviour can be induced in the female (Swelum et al., 2018b). Previous studies have shown that 
when associated with eCG and a luteolytic agent, use for the third time in short protocols is viable for the 
synchronization and induction of oestrus and ovulation in ewes without affecting the percentages of oestrus 
presentation (Pinna et al., 2012; Bazzan et al., 2013; Vilariño et al., 2013; Da Silva et al., 2014) since the 
eCG favours follicular growth and the consequent production of oestradiol (Murphy, 2012). 
Cox et al. (2012), using a seven-day protocol with reused CIDR with an injection of 0.125 mg 
cloprostenol and 350 IU eCG on the removal of the device, obtained 95.7% of ewes that showed oestrus in 
the reproductive season. These results differ from those reported by Güngör et al. (2009), who obtained 
66.67% of females in oestrus when evaluating reused CIDR for 12 days plus an injection of 500 IU of eCG in 
multiparous ewes in anoestrous. They also differ from those of  Biehl et al. (2019), who found 70% of oestrus 
of in cyclic multiparous ewes with reused CIDR in protocols of 7 or 11 days plus the application of 300 IU of 
eCG and 6.70 mg of Dinoprost on withdrawal of the device. Although a luteolytic agent was not used at the 
end of the treatment in the present study, the high percentage of oestrous response could be attributed to 
the use of eCG, because a greater percentage of ewes (85.94%) showed P4 levels greater than 1ng/mL at 
the beginning of the treatments, suggesting that most ewes were in a regular ovarian cycle. 
 
 
Table 1 Reproductive variables in primal ewes treated with reused controlled intravaginal release device (9 d 






(n = 16) 
CIDR9 + 
eCG300 
(n = 16) 
CIDR12 + 
eCG200 
(n = 16) 
CIDR12 + 
eCG300 





        
Oestrus response (%) 100 87.50 100 93.75 0.285 0.577 0.078 
Oestrus onset (h)
1
 32.62±2.18 30.00±2.35 31.12±2.73 30.80±2.50 0.495 0.792 0.215 
Oestrus duration (h)
1
 36.37±3.19 34.71±2.67 37.12±2.94 35.20±3.56 0.610 0.574 0.227 
Return of oestrus (%)
2
 12.50 18.75 6.25 6.25 0.629 0.269 0.691 
Gestation  (%)
3









 0.001 0.001 0.823 








 0.001 0.001 0.072 








 0.001 0.001 0.044 
        
a,b,c 
Within a row, values with a common superscript do not differ with (P =0.05) 
1 
Mean ± SE of onset and duration of oestrus after withdrawal of the device
 
2 
Percentage of ewes in oestrus at 17 days after natural service 
3
 Based on progesterone profiles in serum and ultrasound at 30 days after natural service 
CIDR9 + eCG200:controlled intravaginal release device (CIDR) reused 9 d and 200 IU equine chorionic gonadotrophin 
(eCG), CIDR9 + eCG300: CIDR reused 9 d and 300 IU eCG, CIDR12 + eCG200: CIDR reused 12 d and 200 IU eCG, 
CIDR12 + eCG300: CIDR reused 12 d and 300 IU eCG 
 
 
The onset and the duration of oestrus did not differ between treatments (P >0.05), showing at 30 to 32 
hours and lasting from 34 to 36 hours after the device was removed. These results differ from those recorded 
by Pinna et al. (2012), who obtained an oestrus interval of 46.1 ± 14.1 hours and a duration of oestrus of 
52.5 ± 1.2 hours in ewes in anoestrous with reused CIDR for five days plus 5 mg dinoprost and 300 IU of 
eCG one day before removal of the device. Although there was no significant difference owing to the effect 
of the eCG dose, ewes that received 300 IU eCG showed an earlier and more compact oestrous synchrony. 
The addition of eCG to the new or reused CIDR protocols reduces the interval between heat and ovulation 
and increases the diameter of the CL on day 10 after heat (Cox et al., 2012). However, the variation in 
ovarian response after treatment with eCG in reproductive programmes in sheep is influenced by differences 
in doses, breed, nutritional level, seasonal variation, ovarian status and time of application of eCG (Shahneh 
et al., 2006; Rad & Farzaneh, 2007; Moakhar et al., 2012). 
For the duration of the reused CIDR devices (imitation of the luteal phase), the concentration of P4 
was higher (P <0.05) with the CIDR12+eCG300 treatment compared with the other groups. In all treatments, 
P4 concentration was maintained above 1 ng/mL and then decreased at oestrus (experimental day 14). 
Subsequently, P4 concentrations were higher (P <0.05) with the CIDR12+eCG300 treatment only during the 




first five days after breeding (presence of functional CL). The high P4 concentration in treatments with a 
duration of 12 days compared with nine days was probably because of a higher concentration of 
endogenous P4 at the beginning of the protocol and a higher rate of absorption of exogenous progestogen, 
which was reflected in better fertility. In addition, there is evidence of a relationship between P4 
concentrations during treatments, with the ovarian follicular turnover and fertility in sheep (Vilariño et al., 
2013).  
Elevation of serum P4 concentration, which is influenced by the release of P4 from the device, causes 
persistent follicle regression and inhibits the release of gonadotropins from the anterior pituitary gland, 
allowing blockage of oestrus behaviour and ovulation until withdrawal of the device (Swelum et al., 2018b). 
Subsequently, the inhibition disappears on the removal of the device, which causes the stimulation of the 
gonadotropin-releasing hormone pulse from the hypothalamus, which influences the preovulatory increase of 
LH and FSH that results in the re-start of ovarian activity, which culminates in ovulation (Laven, 2019; 






Figure 2 Progesterone concentration in serum from the insertion of the reused controlled intravaginal drug 
release device to its withdrawal and the posterior oestrus cycle in primal ewes 
 
a,b,c
 Within a day, means with a common superscript did not differ with P =0.05 
CIDR: controlled intravaginal drug release, eCG: equine chorionic gonadotropin 
CIDR9+eCG200:CIDR reused 9 d and 200 IU eCG, CIDR9+eCG300: CIDR reused 9 d and 300 IU eCG, 
CIDR12+eCG200: CIDR reused 12 d and 200 IU eCG, CIDR12+eCG300: CIDR reused 12 d and 300 IU eCG 
 
 
In previous work it was found that serum P4 concentrations were lower with reused devices compared 
with new devices. However, devices on second and third use are as effective as new ones in synchronizing 
oestrous and ovulation when they are used in short-term protocols in ewes in the reproductive period and in 
anoestrus (Cox et al., 2012; Pinna et al., 2012; Vilariño et al., 2013). On the other hand, Swelum et al. 
(2015), evaluated devices that were used up to six times in cyclic ewes during a short synchronization 
protocol, and found no differences in P4 concentration between treatments, but obtained higher percentages 
of induced oestrus, pregnancy, fertility and twin births with new devices and those which were only used for a 
second time. 
The percentage of pregnancies and return to oestrus did not differ between treatments (P >0.05) in the 
duration of the reused CIDR or the dose of eCG in primal ewes (Table 1). The ewes that showed oestrus at 
17 days after natural service were served and became pregnant (except one in the CIDR9+eCG300 
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treatment), which suggests that although not all the ewes were pregnant in the first oestrus, they were 
prepared physiologically to ovulate a healthy follicle in the second oestrus The average gestation percentage 
of all reused CIDR treatments was 87.50%, which was higher than those reported by Da Silva et al. (2014), 
who evaluated the application of first-, second-, and third-use CIDR in short protocols plus the injection of 
0.263 mg of PGF2α and 250 IU of eCG on removal (73.3%, 72.7%, and 64.7%, respectively) in cyclic ewes, 
and in those reported by Swelum et al. (2018b), who obtained 65% gestation in sheep with natural 
insemination in the reproductive period with CIDR devices of second use. 
The results confirm what was reported by Biehl et al. (2019), who concluded that the gestation 
percentage is not affected by the reuse of the CIDR, in either long or short synchronization treatments when 
ewes are inseminated during the breeding season. They also support those of Güngör et al. (2009), who 
applying a long procedure with reused CIDR in ewes with natural mount in anoestrus. However, the 
percentage of pregnancy and fertility might be affected by the number of times that the devices have been  
used in the past (Swelum et al., 2015; Swelum et al., 2018b) and the type of breeding (natural or artificial 
insemination (AI)) (Pinna et al., 2012). 
In terms of prolificacy, the CIDR12+eCG300 treatment produced the highest (1.44) number of lambs 
per ewe which was significantly different (P = 0.001) from CIDR9+eCG200 (1.21) and CIDR9+eCG300 
(1.20) treatments, but not different from the CIDR12+eCG200 group (1.31). However, with the CIDR used for 
12 days prolificity increased (P = 0.001) by 13% (1.37) relative to its use for nine days (1.20). These results 
can be attributed to the correct development of functional CL and the increase in P4 secretion to provide the 
endometrium with the appropriate conditions during embryo implantation and for the maintenance of 
pregnancy. In the CIDR9+eCG200 treatment, the abortions of two lambs in two ewes (one lamb/ewe) were 
presented in the last third of pregnancy. 
According to Vilariño et al. (2013), there is a relationship between P4 concentrations during reused 
CIDR treatments, ovarian follicular turnover and fertility in ewes. In addition, Cox et al. (2012) consider that 
the increase in the size of the CL 10 days after oestrus in sheep treated with eCG is related to the ovulation 
of a greater number of healthy follicles. On the other hand, the synthesis of interferon tau (INTT) by the 
embryo is positively correlated with P4 production, so that high amounts of P4 circulating in the female, 
induce maternal recognition of pregnancy by increasing INTT production, which favours embryonic survival 
and development (Kerbler et al., 1997). 
In terms of twinning, the CIDR12+eCG300 treatment obtained the highest percentage (P =0.001) with 
43.75%. The lowest percentage was for the CIDR9+eCG200 treatment at 21.43%, with no differences 
between this treatment and CIDR9+eCG300 and CIDR12+eCG200 (26.66% and 37.50%, respectively). The 
12 days of duration of the device influenced (P =0.001) the incidence of twinning births and the 300 IU dose 
of eCG increased (P =0.044) the presentation of twinning births. This contrasts with that reported by Swelum 
et al. (2018b), who obtained twinning deliveries with new CIDRs (42.9%) and CIDRs used for the second 
time (63.16%) in combination with 300 IU of eCG without statistical differences compared with devices that 
were used up to six times, which presented only single deliveries in sheep in the breeding season, which can 
be attributed to the greater number of mature ovulated follicles during oestrus. In addition, previous studies 
have shown that the characteristics of the ovulatory follicle and the subsequent luteal phase do not differ 
among sheep treated with first, second and third use of devices (Pinna et al., 2012; Vilariño et al., 2013). On 
the other hand, the addition of eCG to ewe synchronization programmes increases the ovulation rate, which 
triggers multiple births in a greater proportion (Murphy, 2012). 
 
Conclusions  
Use of a CIDR device for a second time in primal ewes results in sufficient relaease of progesterone to 
synchronize oestrous, which allows the use of CIDR devices to be maximized. The best results in 
reproductive efficiency in the prolificity index and twinning deliveries were obtained when the reused CIDR 
was inserted for 12 days with 300 IU of eCG injected upon its removal. 
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